Korean Journal of Clinical Oncology (대한종양외과학회지)

Korean Society of Surgical Oncology (대한종양외과학회)
권호 표지
DOI QR코드

DOI QR Code

Adjuvant chemotherapy in patients with stage II colon cancer

  • Kim, Hyung Jin (Department of Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2018.12.30
  • Accepted : 2018.12.31
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Boland GM, Chang GJ, Haynes AB, Chiang YJ, Chagpar R, Xing Y, et al. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer 2013;119:1593-601. https://doi.org/10.1002/cncr.27935
  2. Bockelman C, Engelmann BE, Kaprio T, Hansen TF, Glimelius B. Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature. Acta Oncol 2015;54:5-16. https://doi.org/10.3109/0284186X.2014.975839
  3. Gill S, Loprinzi CL, Sargent DJ, Thome SD, Alberts SR, Haller DG, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 2004;22:1797-806. https://doi.org/10.1200/JCO.2004.09.059
  4. Quasar Collaborative Group, Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007;370:2020-9. https://doi.org/10.1016/S0140-6736(07)61866-2
  5. Tournigand C, Andre T, Bonnetain F, Chibaudel B, Lledo G, Hickish T, et al. Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. J Clin Oncol 2012;30:3353-60. https://doi.org/10.1200/JCO.2012.42.5645
  6. Kuebler JP, Wieand HS, O'Connell MJ, Smith RE, Colangelo LH, Yothers G, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007;25:2198-204. https://doi.org/10.1200/JCO.2006.08.2974
  7. Ng K, Schrag D. Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch? J Clin Oncol 2010;28:3207-10. https://doi.org/10.1200/JCO.2010.28.9314
  8. Kim MJ, Baek S, Ko S. The efficacy of chemotherapy in the patients with stage II colon cancer associated with number of high-risk factors. Korean J Clin Oncol 2018;14:116-9. https://doi.org/10.14216/kjco.18020